Company Filing History:
Years Active: 2001
Title: Mark Henkemeyer: Innovator in Neural Receptor Tyrosine Kinase
Introduction
Mark Henkemeyer is a distinguished inventor based in Toronto, Canada. He has made significant contributions to the field of molecular biology, particularly in the study of receptor tyrosine kinases. His innovative work has implications for both diagnostic and therapeutic applications.
Latest Patents
Henkemeyer holds a patent for a novel receptor tyrosine kinase protein and its isoforms, which are expressed in migrating axons. The patent also includes nucleic acid molecules encoding these novel protein isoforms. His invention outlines methods for identifying substances that can bind to the receptor protein, as well as methods for screening for agonists or antagonists of this binding. Additionally, the patent describes diagnostic and therapeutic methods utilizing the protein and nucleic acid molecules.
Career Highlights
Mark Henkemeyer is affiliated with Mount Sinai Hospital Corporation, where he continues to advance research in his field. His work has garnered attention for its potential to impact various medical applications.
Collaborations
Henkemeyer has collaborated with notable scientists, including Anthony J Pawson and Kenneth Letwin. These partnerships have further enriched his research and innovation efforts.
Conclusion
Mark Henkemeyer is a prominent figure in the realm of receptor tyrosine kinase research, with a patent that showcases his innovative contributions to science. His work holds promise for future advancements in diagnostics and therapeutics.